In vitro activity of DU-6681a, an active form of the new oral carbapenem compound DZ-2640, in comparison with that of R-95867, faropenem and oral cephalosporins

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 1, 2000, Pages 101-108

  Okuda, Jun ^a,b   Otsuki, Masako ^a   Oh, Takanori ^a   Nishino, Takeshi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(6,7 DIHYDRO 5H PYRROLO[1,2 A]IMIDAZOL 6 YL)THIO] 6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID PIVALOYLOXYMETHYL ESTER; 6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID; 6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID PIVALOYLOXYMETHYL ESTER; AMPICILLIN; BETA LACTAMASE; CARBAPENEM; CEFCAPENE; CEFOTIAM; CEFPODOXIME; CEPHALOSPORIN; CILASTATIN; DZ 6681A; FROPENEM; IMIPENEM; MEROPENEM; METICILLIN; PANIPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; 3 [(6,7 DIHYDRO 5H PYRROLO[1,2 A]IMIDAZOL 6 YL)THIO] 6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID; ANTIINFECTIVE AGENT; BETA LACTAM; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; LACTAM;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS; BACTEROIDES; CITROBACTER FREUNDII; CLOSTRIDIUM; CONTROLLED STUDY; DRUG POTENCY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS AVIUM; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; ESCHERICHIA COLI O157; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MORGANELLA MORGANII; NONHUMAN; PEPTOSTREPTOCOCCUS; PROTEUS MIRABILIS; PROTEUS VULGARIS; PROVIDENCIA RETTGERI; PSEUDOMONAS AERUGINOSA; SALMONELLA; SERRATIA MARCESCENS; SHIGELLA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; VIBRIO CHOLERAE; VIBRIO PARAHAEMOLYTICUS; BACTERIUM; COMPARATIVE STUDY; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; BACTERIA; BETA-LACTAMS; CARBAPENEMS; CEPHALOSPORINS; LACTAMS; MICROBIAL SENSITIVITY TESTS;

EID: 0033926265     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/46.1.101     Document Type: Article

References (9)

1. Hikida, M., Kawashima, K., Yoshida, M. & Mitsuhashi, S. (1992). Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex. Journal of Antimicrobial Chemotherapy 30, 129-34.
2. Edwards, J. R., Turner, P. J., Wannop, C., Withnell, E. S., Grindey, A. J. & Nairn, K. (1989). In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I. Antimicrobial Agents and Chemotherapy 33, 215-22.
3. Nishi, T., Ishida, Y., Sugita, K., Ohtsuka, M., Takemura, M., Hayakawa, I. et al. (1995). DZ-2640, a new oral carbapenem antibiotic, 1: structure activity relationships and in vitro activity. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1995. Abstract F133, p. 136. American Society for Microbiology, Washington, DC.
4. Aoki, H., Sekiguchi, M., Akahane, K., Tsutomi, Y., Korenaga, H., Hayano, T. et al. (1995). DZ-2640, a new oral carbapenem antibiotic, 3: pharmacokinetics and safety in laboratory animals. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1995. Abstract F133, p. 136. American Society for Microbiology, Washington, DC.
5. Sakagawa, E., Otsuki, M., Oh, T. & Nishino, T. (1998). In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem. Journal of Antimicrobial Chemotherapy 42, 427-37.
6. Inoue, E. & Mitsuhashi, S. (1994). In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic. Antimicrobial Agents and Chemotherapy 38, 1974-9.
7. Knapp, C. C., Sierra-Madero, J. & Washington, J. A. (1988). Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone. Antimicrobial Agents and Chemotherapy 32, 1896-8.
8. Japan Society of Chemotherapy. (1981). Method of MIC determination. Chemotherapy 29, 76-9.
9. Moulin, F., Raymond, J., Bergeret, M., Iniguez, J. L., Habib, F., Chemillier-Truong, M. et al. (1995). Failure of the treatment with antibiotics in severe Salmonella infections in children and use of quinolones. Archives de Pediatrie 2, 317-23.